Huons Meditech strengthened its presence in the Latin American market by showcasing its flagship medical devices at Hospitalar 2026, aiming to drive greater visibility and interest among regional partners.
Huons Meditech said Friday that the company showcased its technological prowess and competitive edge at Hospitalar 2026, the largest medical device exhibition in Latin America, held from Tuesday to Friday (local time) in São Paulo, Brazil.
Huons Meditech showcased its products at Hospitalar 2026 held in São Paulo, Brazil. (Courtesy of Huons Meditech)
The Hospitalar exhibition is a key event for medical device and healthcare professionals in Latin America, providing a significant platform to showcase the latest medical technologies and products.
At this year's exhibition, Huons Meditech showcased its flagship aesthetic medical device, the automatic drug injector DermaShine Pro, alongside its specialized multi-needle products for skin boosters.
DermaShine Pro features advanced drug-delivery technology and an intuitive interface. The Premium 9-Pin Needle is a single-use sterile injection needle for both DermaShine Pro and DermaShine Balance. Both devices are certified under CE-MDR.
DermaShine Pro received highly favorable reviews at the exhibition, helping Huons Meditech meet increasing market demand and enhance its credibility and recognition in Brazil and Latin America.
During the event, Huons Meditech focused on expanding its partnership network and discovering new business opportunities through numerous strategic meetings with major local buyers. The company stated that these efforts enabled it to strengthen its brand presence and increase its market share across the region.
“Moving forward, we will continue to participate in various international exhibitions to accelerate our global expansion,” Huons Meditech CEO Ha Chang-woo said.
Kim Ji-hye
댓글
0